Fundraising Fox

Rajesh Devraj

Investor

Venture Partner at Atlas Venture

Cambridge, Massachusetts

Writes $10M – $50M checks · typically $25M

Experience

  1. Rectify PharmaceuticalsPresident & CEOcurrent2022 — presentCambridge, Massachusetts, United States
  2. Washington University School of Medicine in St. LouisBiopharma Advisory Committeecurrent2023 — present
  3. Euclises Pharmaceuticals Inc.Board Director2015 — 2025Greater St. Louis
  4. Euclises Pharmaceuticals Inc.President and Chief Executive Officer2013 — 2014Greater St. Louis
  5. Sail BIOBoard Director2021 — 2024Cambridge, Massachusetts, United States
  6. Disarm TherapeuticsChief Scientific Officer and Co-founder2016 — 2020Cambridge, MA, USA
  7. Indalo TherapeuticsBoard Director2017 — 2020Cambridge, Massachusetts, United States
  8. Antegrin Therapeutics, LLCChairman of the Board of Managers2013 — 2016Greater St. Louis
  9. Padlock Therapeutics Inc.Chief Scientific Officer2014 — 2016Cambridge, Massachusetts
  10. Deciphera PharmaceuticalsScientific Advisory Board2012 — 2014
  11. Deciphera PharmaceuticalsSenior Vice-President2011 — 2012Lawrence, Kansas, United States
  12. Jubilant BiosysSenior Vice-President, Scientific & Portfolio Strategy2010 — 2011
  13. Pfizer Global Research and DevelopmentSenior Director2004 — 2010
  14. Pfizer Global Research and DevelopmentDirector2003 — 2004
  15. Pfizer Global Research and DevelopmentAssociate Director & Science Research Fellow2002 — 2003
  16. Pfizer Global Research and DevelopmentSenior Research Advisor and Section Head2000 — 2002
  17. Searle Discovery Research, Monsanto Life Sciences, Co.Project & Technology Leader1997 — 2000
  18. Searle Discovery Research, Monsanto Life Sciences, Co.Senior Research Investigator1996 — 1997

Skills & more

Strategic Planning4Drug Discovery96Medicinal Chemistry64Drug Design40Drug Development58Pharmaceutical Industry37Lead Change14CRO14Oncology10LC-MS13Biotechnology27Clinical Development20
+12 moreOrganic ChemistryLifesciencesPharmacologyOrganic Synthesispreclinical developmentFundraisingCapital BudgetingImmunologyRInflammationAlliance-buildingClosing Deals

From Rajesh's professional profile.

Deals · 2

Antegrin TherapeuticsBoard seat

via Atlas Venture · filed Aug 2017 · $26M raise

Euclises PharmaceuticalsBoard seat

via Atlas Venture · filed Dec 2016 · $2.7M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Atlas Venture

Frequently asked questions

Who is Rajesh Devraj?
Venture Partner at Atlas Venture
Where does Rajesh Devraj work?
Rajesh Devraj is Venture Partner at Atlas Venture.
What check size does Rajesh Devraj write?
Rajesh Devraj typically writes checks of $10M – $50M.
What boards does Rajesh Devraj sit on?
Rajesh Devraj holds tracked board seats at Antegrin Therapeutics, Antegrin Therapeutics, Euclises Pharmaceuticals.

Shared employers